Las Vegas, NV -- (SBWIRE) -- 09/28/2013 -- PennyStockEarnings team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks. Our Today’s Focus is On: Merrimack Pharmaceuticals Inc (NASDAQ:MACK), Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), ISIS Pharmaceuticals, Inc.(NASDAQ:ISIS), Vical Incorporated (NASDAQ:VICL)
Merrimack Pharmaceuticals Inc (NASDAQ:MACK) Saw its volume 1.03M million shares changed hands when compared with its average daily volume of 1.61M shares. The stock was at $3.97. It has gone down over the last 12 months at -34.81% and marked new low $3.26. Merrimack Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and preparing to commercialize medicines paired with companion diagnostics for the treatment of cancer in the United States.
Has MACK Found The Bottom and Ready To Move Up? Find Out Here
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) settled at $76.10 on below-normal volume of 1.03M shares during the last trading day. The stock has its 12-month high at $89.96 and 52-week low price was $38.44. It traded in a range of $75.16 to $77.51 during the last trading day. Vertex Pharmaceuticals Incorporated engages in discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases .
Has VRTX Found The Bottom And Ready To Gain Momentum? Find Out Here
ISIS Pharmaceuticals, Inc.(NASDAQ:ISIS) traded up on a volume of 1.02 million. Shares have gone up 0.84% to $38.36. Over the last twelve months, the stock has gained 267.43% and faced a worst price of $7.55. Isis Pharmaceuticals, Inc. engages in the discovery and development of antisense drugs using novel drug discovery platform.
What was the Moving Force behind ISIS On Bullish Run? Read This Research Report
Vical Incorporated (NASDAQ:VICL) managed to go neutrally at 1.29 on below-normal volume of 1.01 million shares. The stock settled at $1.29 after floating in a range of $1.27 to $1.30. Its latest price was $1.29, reaching market capitalization of $111.86 million. Its 52-week range has been $1.17 to $4.51. Vical Incorporated engages in the research and development of biopharmaceutical products based on its DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases .
Can Investors Bet on VICL after this News update? Just Go Here And Find Out
PennyStockEarnings.com is keen to discover penny stocks with the potential to make short and long-term gains.
PSE Team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks.
PLEASE NOTE WELL: The employees of PennyStockEarnings.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockEarnings.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockEarnings.com is not offering securities for sale. Neither PennyStockEarnings.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockEarnings.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockEarnings.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer Here: http://www.pennystockearnings.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)